Find a Programme
UK NEQAS provides External Quality Assessment/Proficiency Testing for all major aspects of clinical laboratory testing. To find the programme(s) to match your EQA/PT requirements please use the search function below.
Showing Results: 316 - 330 out of 433
Non-Small Cell Lung Cancer (NSCLC) ALK IHC
|Immunocytochemistry & In-Situ Hybridisation
Non-Small Cell Lung Cancer (NSCLC) ALK ISH *Pilot*
|Immunocytochemistry & In-Situ Hybridisation
Non-Small Cell Lung Cancer (NSCLC) PD-L1 IHC *Pilot*
|Immunocytochemistry & In-Situ Hybridisation
Non-Small Cell Lung Cancer (NSCLC) ROS1 FISH *Pilot*
|Immunocytochemistry & In-Situ Hybridisation
Non-Small Cell Lung Cancer (NSCLC) ROS1 IHC *Pilot*
|Immunocytochemistry & In-Situ Hybridisation
NPM1 Mutation Status
|Leucocyte Immunophenotyping
To assess a laboratories ability to accurately detect the NPM1 Mutation Status using molecular methods. NPM1 mutation load will reflect levels seen at diagnosis.
NT-proBNP
|Cardiac Markers
NTRK fusions
|Genomics (GenQA)
Pan-cancer NTRK fusions testing in FFPE
Oncogenetic disorders *
|Genomics (GenQA)
Clinical diagnosis and genetic counselling based on family history and test results: online educational case scenario with multiple stages.
Paediatric Acute Leukaemia Translocations
|Leucocyte Immunophenotyping
Paediatric Bilirubin
|Clinical Chemistry (Birmingham Quality)
Assessment of analytical bias and its consistency across time
Paraneoplastic Antibodies
|Immunology, Immunochemistry & Allergy (IIA)
Autoimmunity EQA scheme
Parasite Serology
|Parasitology
To assess a laboratory's ability to identify the parasite antibody present in the serum sample.
Paroxysmal Nocturnal Haemoglobinuria
|Leucocyte Immunophenotyping
To assess a laboratory's ability to detect and quantify PNH red cells, granulocytes and monocytes.
Parvovirus B19 and Rubella Serology
|Microbiology
To provide EQA for laboratories determining the presence of IgM and IgG to Rubella, IgM and IgG to Parvovirus B19